Prostate cancer Posts - Page 32 of 80 on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Comparison between low and high dose brachytherapy followed by radiation in prostate cancer

Comparison between low and high dose brachytherapy followed by radiation in prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to compare urinary symptoms in men with localized prostate cancer treated with either low-dose or high-dose rate brachytherapy in combination with radiation therapy. The authors concluded the both low-dose and high-dose brachytherapy with IMRT was safe and well-tolerated by patients. However, it took longer to recover...

Read More

Comparing the side effects of treatment options for localized prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes and side effects of radical prostatectomy, external beam radiation therapy, and active surveillance in men with localized prostate cancer. This study concluded that radical prostatectomy led to a greater decrease in sexual function and urinary continence compared to the other two treatment...

Read More

Immunotherapies and their use in prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to review immunotherapies available for prostate cancer treatment. The authors concluded that further research into immunotherapy for prostate cancer is needed to more accurately assess the effect of immunotherapies as a viable treatment option for prostate cancer. Some background Targeting the immune system is a...

Read More

Colon Cancer Patient Advocate Shares Her Story

Colon Cancer Patient Advocate Shares Her Story

Posted by on Jun 26, 2017 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

In April, the American Association for Cancer Research (AACR) held a free education event on cancer called​ Progress and Promise Against Cancer in Washington, D.C.  Surrounded by experts in cancer research, Kim Hall Jackson shared her patient story. One evening in 2008, Jackson, an event planner, was running the mayor’s inaugural event in...

Read More

Searching for men to test focal therapy for ablation of prostate cancer

Posted by on Jun 6, 2017 in Prostate cancer | 0 comments

In a nutshell This study aims to test the effectiveness of focal ablation (laser therapy used to remove and kill cancer cells) of large prostate cancer sites using ultrasound and biopsy (tissue samples taken from the cancer site) one year after treatment. The main outcome to be measured will be the removal of cancer cells confirmed by a negative biopsy...

Read More

Searching for patients to test the effectiveness of docetaxel and carboplatin in the treatment of advanced prostate cancer

Posted by on Jun 6, 2017 in Prostate cancer | 0 comments

In a nutshell The aim of this trial is to determine the effectiveness of a combination of the chemotherapies docetaxel (Taxotere) and carboplatin (Paraplatin) in advanced (spread beyond the prostate) prostate cancer. The main outcome to be measured is the number of patients who experience a decrease of 50% in prostate specific...

Read More

Quick Guide: Understanding the Importance of the FDA’s Keytruda Approval

Quick Guide:  Understanding the Importance of the FDA’s Keytruda Approval

Posted by on May 26, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Lung cancer, Melanoma, Prostate cancer | 2 comments

In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ.  In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features.  Achieving this goal is closer than you think! This week the FDA announced accelerated approval** of a...

Read More